Distinction between HLA class I-positive and -negative cervical tumor subpopulations by multiparameter DNA flow cytometry

Cytometry

Volumn 41, Issue 1, 2000, Pages 73-80

  Corver, Willem E ^a   Koopman, Louise A ^a   Mulder, Arend ^a,b   Cornelisse, Cees J ^a   Fleuren, Gert Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SVM Foundation for the Advancement of Public Health and Environmental Protection   (Netherlands)

Author keywords

Cervical carcinoma; Down regulation; Flow cytometry; HLA class I; Tumor heterogeneity

Indexed keywords

CD45 ANTIGEN; HLA ANTIGEN CLASS 1; KERATIN; VIMENTIN;

ARTICLE; CELL ISOLATION; CELL SUBPOPULATION; DNA CONTENT; DOWN REGULATION; EPITHELIUM CELL; FLOW CYTOMETRY; GENETIC HETEROGENEITY; HISTOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; PRIORITY JOURNAL; SOLID TUMOR; STROMA CELL; TUMOR CELL CULTURE; UTERINE CERVIX CANCER;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD45; DNA, NEOPLASM; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; GENETIC HETEROGENEITY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; KERATINS; PLOIDIES; UTERINE CERVICAL NEOPLASMS;

EID: 0034284352     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0320(20000901)41:1<73::AID-CYTO10>3.0.CO;2-5     Document Type: Article

References (24)

1. Natural history of HLA expression during tumour development
2. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
3. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance
4. Mechanisms of loss of HLA class I expression on colorectal tumor cells
5. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines
6. Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines
7. Allelic loss and prognosis in carcinoma of the uterine cervix
8. PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue
9. One tube triple staining method for the flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation
10. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy and flow cytometry
11. Four-color multiparameter DNA flow cytometric method to study phenotypic intratumor heterogeneity in cervical cancer
12. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen
13. Coexpression of intermediate filament polypeptides in human fetal and adult tissues
14. Differentiation-related changes of cytokeratin expression in cultured keratinocytes and in fetal, newborn, and adult epidermis
15. Simultaneous measurement of two cellular antigens and DNA using fluorescein-isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan
16. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer
17. High levels of DNA index heterogeneity in advanced breast carcinomas
18. Heterogeneity in renal-cell carcinoma and its impact on prognosis - A flow cytometric study
19. Geographic distribution of co-dominant DNA stemlines in breast carcinoma
20. Keratin expression in cervical cancer
21. Molecular genetic analysis of flow-sorted ovarian tumour cells: Improved detection of loss of heterozygosity
22. Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastasis
23. Characterization of two human monoclonal antibodies reactive with HLA-B12 and HLA-B60, respectively, raised by in vitro secondary immunization of peripheral blood lymphocytes
24. Multiple genetic alterations cause frequent and heterogeneous human histocompatability leukocyte antigen class I loss in cervical cancer